DK325587A - HYDROGENED 1-BENZOOXACYCLOYLKYL PYRIDINE CARBOXYLIC ACID COMPOUNDS AND SALTS THEREOF AND THEIR PREPARATION AND USE - Google Patents

HYDROGENED 1-BENZOOXACYCLOYLKYL PYRIDINE CARBOXYLIC ACID COMPOUNDS AND SALTS THEREOF AND THEIR PREPARATION AND USE

Info

Publication number
DK325587A
DK325587A DK325587A DK325587A DK325587A DK 325587 A DK325587 A DK 325587A DK 325587 A DK325587 A DK 325587A DK 325587 A DK325587 A DK 325587A DK 325587 A DK325587 A DK 325587A
Authority
DK
Denmark
Prior art keywords
denotes
alkylcarbamyl
oxygen atom
salts
optionally
Prior art date
Application number
DK325587A
Other languages
Danish (da)
Other versions
DK325587D0 (en
Inventor
Wolfgang Froestl
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DK325587D0 publication Critical patent/DK325587D0/en
Publication of DK325587A publication Critical patent/DK325587A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Novel hydrogenated 1-benzooxacycloalkylpyridinecarboxylic acid compounds of the formula <IMAGE> in which either R1 denotes carboxyl, lower alkoxycarbonyl, carbamyl, N-lower alkylcarbamyl, N,N-dilower alkylcarbamyl or optionally acylated hydroxymethyl and R2 denotes hydrogen, an optionally etherified or acylated hydroxyl group or an optionally acylated amino group or R1 denotes hydrogen and R2 represents carboxyl, lower alkoxycarbonyl, carbamyl, N-lower alkylcarbamyl, N,N-dilower alkylcarbamyl or optionally acylated hydroxymethyl, R3 denotes hydrogen or lower alkyl, alk denotes lower alkylene or lower alkylidene, the ring A is unsubstituted or mono- or polysubstituted by hydroxyl, lower alkoxy, lower alkanoyloxy, halogen, lower alkyl and/or trifluoromethyl, the dashed line is intended to express that a single bond or a double bond is present and either X and Y in each case denotes an oxygen atom and n represents 1 or X represents a methylene group, Y denotes an oxygen atom and n represents 1 or X represents an oxygen atom, Y denotes a methylene group and n represents 1 or X represents a direct bond, Y represents an oxygen atom and n represents 2, and their tautomers and/or salts are described. These compounds can be used as pharmaceutical active substances and can be prepared in a manner known per se.
DK325587A 1986-06-26 1987-06-25 HYDROGENED 1-BENZOOXACYCLOYLKYL PYRIDINE CARBOXYLIC ACID COMPOUNDS AND SALTS THEREOF AND THEIR PREPARATION AND USE DK325587A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH258886 1986-06-26

Publications (2)

Publication Number Publication Date
DK325587D0 DK325587D0 (en) 1987-06-25
DK325587A true DK325587A (en) 1987-12-27

Family

ID=4237161

Family Applications (1)

Application Number Title Priority Date Filing Date
DK325587A DK325587A (en) 1986-06-26 1987-06-25 HYDROGENED 1-BENZOOXACYCLOYLKYL PYRIDINE CARBOXYLIC ACID COMPOUNDS AND SALTS THEREOF AND THEIR PREPARATION AND USE

Country Status (16)

Country Link
EP (1) EP0252005B1 (en)
JP (1) JPH0699420B2 (en)
AT (1) ATE65084T1 (en)
AU (1) AU617988B2 (en)
CA (1) CA1322553C (en)
CY (1) CY1783A (en)
DD (1) DD279674A5 (en)
DE (1) DE3771280D1 (en)
DK (1) DK325587A (en)
ES (1) ES2044970T3 (en)
FI (1) FI91064C (en)
GR (1) GR3002308T3 (en)
HK (1) HK134994A (en)
HU (1) HU207061B (en)
IE (1) IE59881B1 (en)
PT (1) PT85157B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0322361A3 (en) * 1987-12-23 1990-01-24 Ciba-Geigy Ag Hydrogenated 1-benzooxacycloalkyl pyridine-carboxylic-acid compounds
US5342616A (en) * 1988-06-20 1994-08-30 The Wellcome Foundation Limited Method of administering tissue plasminogen activator
DE3901814A1 (en) * 1988-07-28 1990-02-01 Bayer Ag SUBSTITUTED AMINOMETHYLZETRALINE AND ITS HETEROCYCLIC ANALOG
ATE121740T1 (en) * 1989-03-22 1995-05-15 Ciba Geigy Ag NEW BENZOTHIOPYRANYLAMINES.
US5189179A (en) * 1990-08-29 1993-02-23 Merrell Dow Pharmaceuticals Inc. Serotonin 5ht1a agonists
US5212170A (en) * 1991-06-21 1993-05-18 American Home Products Corporation Psychotropic piperidinylmethyl benzodioxans
US5221745A (en) * 1991-06-21 1993-06-22 American Home Products Corp. Psychotropic piperidinylmethyl benzodioxans
US5182292A (en) * 1991-06-21 1993-01-26 American Home Products Corporation Psychotropic piperidinylmethyl benzodioxans
US5240943A (en) * 1991-12-19 1993-08-31 G. D. Searle & Co. Benzopyran class iii antiarrhythmic agents
FR2694005B1 (en) * 1992-07-21 1994-08-26 Adir New aminoalkylchromones, methods for their preparation and pharmaceutical compositions containing them.
JP3546657B2 (en) * 1997-08-29 2004-07-28 株式会社トヨトミ Water heater can body structure
EP1831165A1 (en) * 2004-12-20 2007-09-12 F. Hoffmann-Roche AG 4-aminopiperidine derivatives
JP6875279B2 (en) 2014-12-05 2021-05-19 ゼンメルワイス ユニバーシティ Preventive or therapeutic agents for cancer or its metastasis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1366479A (en) * 1962-08-20 1964-07-10 Res Lab Dr C Janssen Nv Process for the production of novel piperidine derivatives and their salts
GB1520801A (en) * 1975-01-16 1978-08-09 Lafon Labor Benzodioxanyl and benzofuranylmethylamines
AU552050B2 (en) * 1981-05-26 1986-05-22 Smithkline Beckman Corporation N-substituted azeheterocyclic carboxylic acids and their esters
CA1183847A (en) * 1981-10-01 1985-03-12 Georges Van Daele N-(3-hydroxy-4-piperidinyl)benzamide derivatives
FR2524887A1 (en) * 1982-04-08 1983-10-14 Bouchara Emile NOVEL CYANOGUANIDINES, PROCESS FOR OBTAINING THEM AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME
DE3411993A1 (en) * 1984-03-31 1985-10-10 Bayer Ag, 5090 Leverkusen SUBSTITUTED BENZOPYRANS, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE IN MEDICINAL PRODUCTS
JPH0816108B2 (en) * 1986-02-21 1996-02-21 株式会社クラレ 3,4-Dihydro-2H-benzopyran derivative and its pharmaceutical use

Also Published As

Publication number Publication date
HU207061B (en) 1993-03-01
DK325587D0 (en) 1987-06-25
PT85157A (en) 1987-07-01
FI872807A (en) 1987-12-27
FI872807A0 (en) 1987-06-24
PT85157B (en) 1990-03-30
IE871694L (en) 1987-12-26
DD279674A5 (en) 1990-06-13
CA1322553C (en) 1993-09-28
FI91064C (en) 1994-05-10
IE59881B1 (en) 1994-04-20
CY1783A (en) 1995-10-20
GR3002308T3 (en) 1992-12-30
ES2044970T3 (en) 1994-01-16
JPS638382A (en) 1988-01-14
HUT48622A (en) 1989-06-28
HK134994A (en) 1994-12-09
AU8125587A (en) 1989-05-18
FI91064B (en) 1994-01-31
AU617988B2 (en) 1991-12-12
ATE65084T1 (en) 1991-07-15
JPH0699420B2 (en) 1994-12-07
DE3771280D1 (en) 1991-08-14
EP0252005A1 (en) 1988-01-07
EP0252005B1 (en) 1991-07-10

Similar Documents

Publication Publication Date Title
DK325587A (en) HYDROGENED 1-BENZOOXACYCLOYLKYL PYRIDINE CARBOXYLIC ACID COMPOUNDS AND SALTS THEREOF AND THEIR PREPARATION AND USE
BR9305182A (en) Pharmaceutical compound and formulation
DK382388A (en) 2- (HETEROCYCLYLALKYL) IMIDAZOPYRIDINES
DK184388D0 (en) 3H-1,2,3-TRIAZOLOOE4,5-DAAPYRIMIDINER
ATE114653T1 (en) HYDROXYALKYLFURANYL DERIVATIVES.
ATE139441T1 (en) USE OF 2-IMINOTHIAZOLIDINE-4-ONE DERIVATIVES AS NOVEL DRUG INGREDIENTS
DK0461574T3 (en) Drugs containing 3,7-diazabicyclo (3,3,1) nonane compounds
ES8707923A1 (en) Benzamides and salts.
NO872982D0 (en) NEW TETRACYCLIC INSIDE DERIVATIVES.
ES2005777A6 (en) Hydrogenated pyridine derivatives.
SE7905631L (en) NEW OXOTIA ASSOCIATIONS

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment
AHB Application shelved due to non-payment